Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - CHANGE IN WORKING CAPITAL
Change in Working Capital YMAB - Y-mAbs Therapeutics, Inc.
-19.7 M
LAST VALUE
-64.60%
2 YEAR CAGR
-234.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR